NASDAQ:KZIA

Kazia Therapeutics Stock Predictions

etoro logo Buy KZIA
*Your capital is at risk
$10.95
-0.84 (-7.12%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

KZIA Prediction Chart

KZIA Predictions History

Latest community submissions for KZIA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 28, 2026 $7.58 +6.00% $6.56 X 84.47% 0
Jan 28, 2026 $7.42 +3.75% $6.56 X 86.92% 0
Jan 28, 2026 $8.49 +7.06% $6.56 X 70.58% 0
Jan 15, 2026 $6.33 -7.50% $7.01 X 90.25% 0
Jan 15, 2026 $6.52 -4.69% $7.01 X 93.00% 0
Jan 15, 2026 $9.40 +37.43% $7.01 V 65.91% 1
Jan 7, 2026 $5.91 -9.90% $6.68 X 88.48% 0
Jan 7, 2026 $6.97 +6.19% $6.68 V 95.72% 1
Jan 7, 2026 $7.70 +17.38% $6.68 V 84.73% 1
Jan 5, 2026 $5.67 +13.34% $5.64 V 99.44% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KZIA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KAZIA THERAPEUTICS LIMITED
Kazia Therapeutics
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Thera...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE